×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (Epo ) is widely used clinically to treat anemia associated with various clinical conditions including cancer.21860424 2012
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) is currently used in low-risk MDS, where it successfully corrects anemia in 50-70% of patients.22596089 2012
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) deficiency or inadequate EPO secretion in response to bleeding may result in profound or prolonged anaemia after cardiac surgery.28150286 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) has been used to treat anemia of cancer patients, because it stimulates erythropoiesis.28247960 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin , iron loading or transfusions are used to decrease preoperative anemia , a predisposing factor for blood loss.28338491 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) is a well-known hormone that is clinically used for the treatment of anemia .28383559 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
AlteredExpression
BEFREE
Erythropoietin (EPO ), known primarily for its erythropoietic activity, is commonly used clinically to treat anemia of chronic kidney disease.28629513 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
EPO has been widely used in the treatment of chronic renal failure, cancer, and chemotherapy-related anemia for three decades.28629521 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) is a heavily glycosylated hormone whose recombinant forms are used for treatment of anaemia .28706253 2017
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin Fc (EPO -Fc) fusion proteins are potential drug candidates that have been designed for the treatment of anemia in humans by stimulating erythrocyte production.29198116 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.29374477 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease.29746307 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Epoetin -α reduced RBC transfusions and increased the time-to-first-transfusion compared with placebo.Thus, epoetin -α significantly improved anemia outcomes in low-risk MDS.29895954 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin response to anaemia in heart failure.30068234 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) deficiency and resistance to endogenous EPO is an important pathophysiological feature in anemia of chronic kidney disease (CKD).30136086 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (Epo ) is used for the treatment of cancer‑associated anaemia .30483799 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin is used in a few patients with anaemia to overcome functional iron deficiency, and blood transfusion is being restricted to refractory cases or acute life-threatening situations.30544934 2018
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ), a hematopoietic growth factor, acts primarily to stimulate erythroid cell production, and is clinically used to treat anemia .30656553 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
AlteredExpression
BEFREE
Erythropoietin levels were inappropriately low in relation to the degree of anaemia , but, in contrast to low haemoglobin, not directly associated with joint damage progression.30941747 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin (EPO ) is one of the most successful biopharmaceuticals in history and is used for treating anemia of different origins.30964047 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
EPO is usually to treat anemia in CKD and also improved in cognitive function.31447360 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
Erythropoietin was administered for recurrent AZT-induced anaemia .31471363 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
GeneticVariation
BEFREE
Erythropoietin stimulating agents (ESAs), which are the cornerstone therapy for anemia patients with chronic kidney disease and cancer, are associated with increased risks for cancer, cancer-related mortality, progression of disease, and thromboembolic events.31596520 2019
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia .
22644842 2012
×
Entrez Id: 2056
Gene Symbol: EPO
EPO
Anemia
0.500
Biomarker
BEFREE
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.
28078434 2017